Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts


  Free Subscription

Articles published in BMJ

Retrieve available abstracts of 10 articles:
HTML format
Text format

Single Articles

    November 2016
    Trial of novel leukaemia drug is stopped for second time after two more deaths.
    BMJ. 2016;355:i6376.
    PubMed     Text format    

    October 2016
  2. MAYOR S
    Risk of leukaemia is no higher in children living near UK nuclear sites, finds report.
    BMJ. 2016;355:i5337.
    PubMed     Text format    

    August 2016
  3. HEY SP, Kesselheim AS
    The FDA, Juno Therapeutics, and the ethical imperative of transparency.
    BMJ. 2016;354:i4435.
    PubMed     Text format    

    July 2016
  4. DYER O
    FDA lifts hold on cancer immunotherapy trial placed after patients died.
    BMJ. 2016;354:i3965.
    PubMed     Text format    

    Drug previously available only through Cancer Drugs Fund is approved for NHS use.
    BMJ. 2016;354:i3800.
    PubMed     Text format    

    June 2016
  6. JOPPI R, Gerardi C, Bertele' V, Garattini S, et al
    Letting post-marketing bridge the evidence gap: the case of orphan drugs.
    BMJ. 2016;353:i2978.
    PubMed     Text format    

    January 2016
    US regulator stops leukemia treatment trial after three patients die.
    BMJ. 2016;354:i3893.
    PubMed     Text format    

  8. THOMAS AE, Baird SF, Anderson J
    Purpuric and petechial rashes in adults and children: initial assessment.
    BMJ. 2016;352:i1285.
    PubMed     Text format    

  9. CHAVDA SJ, Dearden C
    Interesting case of lymphocytosis and splenomegaly.
    BMJ. 2016;352:i1227.
    PubMed     Text format    

    January 2015
  10. CHAVDA SJ, Iyengar S, Dearden C
    An unusual case of severe anaemia and lymphocytosis.
    BMJ. 2015;350:h2673.
    PubMed     Text format    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.